graphpad prism v.8.0.2.263 (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
graphpad prism v.8.0.2.263
Graphpad Prism V.8.0.2.263, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graphpad+prism+v%2E8%2E0%2E2%2E263/graphpad+prism+software/pm39993649-154-5-5
Average 90 stars, based on 1 article reviews
Graphpad Prism V.8.0.2.263, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graphpad+prism+v%2E8%2E0%2E2%2E263/graphpad+prism+software/pm39993649-154-5-5
Average 90 stars, based on 1 article reviews
graphpad prism v.8.0.2.263 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: PRTN3 promotes IL33/Treg-mediated tumor immunosuppression by enhancing the M2 polarization of tumor-associated macrophages in lung adenocarcinoma. Article Snippet: The immunosuppressive tumor microenvironment (TME) shaped by tumor-associated macrophages (TAMs) is essential for lung adenocarcinoma (LUAD) immune tolerance and tumor progression.. Here, we first reported that proteinase 3 (PRTN3) promoted the alternative activation (M2) of TAMs and enhanced IL33/regulatory T cells (Tregs)-mediated tumor immunosuppression in LUAD.. Firstly, clinical analysis revealed PRTN3 was highly expressed in TAMs and correlated with the tumor progression and poor prognosis in LUAD patients. Article Title: Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response Article Snippet: All data were analyzed using Article Title: DIP2 is a unique regulator of diacylglycerol lipid homeostasis in eukaryotes Article Snippet: Data were processed and analysed using Microsoft Excel and Article Title: Delta opioid peptide [D-ala2, D-leu5]-Enkephalin's ability to enhance mitophagy via TRPV4 to relieve ischemia/reperfusion injury in brain microvascular endothelial cells. Article Snippet: These data were statistically presented as mean±SEM and graphed using |